#abval25

5th International

Antibody Validation Meeting

  • University of Bath
  • 09/09/25  - 11/09/25
  • 25 Speakers

In September of 2025 we were thrilled to welcome the most delegates, speakers and poster presenters in the Antibody Validation Meeting series' history to Bath.

The meeting saw 25 fantastic talks and engaging discussions amongst the 125 delegates on themes such as AI, education and spatial technologies as they relate to antibodies. The event was organised by CiteAb, the University of Bath and AstraZeneca.

Selected photos

  • Session audience
  • Poster session and presenters
  • Conference social event
  • Presentation and session audience
  • Andrew Buchanan's presentation

You can see all of the photos from the event on our Facebook page.

The talks

Ulf Landegren
Ulf Landegren (Uppsala University): Minimizing antibody cross-reactivity and revealing dynamic protein activity states via dual recognition in solution and in situ.
Stefan Schuechner
Stefan Schuechner (Medical University of Vienna): Protein Phosphatase 2A carboxy terminus: how insufficient validation of post-translational modification specific antibodies misled the field for over 20 years.
Amy Turner
Amy Turner (Proteintech): Epitope-Mapped Recombinant Antibodies: A New Standard in Antibody Validation.
Andrew Bradbury
Andrew Bradbury (Specifica, an IQVIA business): The AIntibody challenge: an update on the use of AI/ML in antibody discovery.
Will Howat
Will Howat (Abcam): Antibody Quality is not just about specificity.
Johan Duchêne
Johan Duchêne (Ludwig Maximilian University of Munich): The DARC Side of Antibodies.
Roberto Polakiewicz
Roberto Polakiewicz (Cell Signaling Technology): Antibody validation in the age of spatial and single cell biology.
Andrew Buchanan
Andrew Buchanan (Stealth Mode Biotech): A perspective on antibody generation in the age of genAI.
Michael Weiner
Michael Weiner (Precision BioTools): MILKSHAKE and Sundae: Sweet Solutions to the Bitter Problem of anti-PTM Specific Antibody Validation.
Carl Laflamme
Carl Laflamme (Neuro-SGC, YCharOS initiative): Antibody Validation as a Scientific Discipline: Lessons and Challenges from YCharOS.
Andrea Radtke
Andrea Radtke (Leica Microsystems): It takes a community: Impact of HuBMAP and grassroots efforts to characterize antibodies for spatial biology applications.

More talks will be uploaded as they become available.